1. Home
  2. TIL vs SUNS Comparison

TIL vs SUNS Comparison

Compare TIL & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • SUNS
  • Stock Information
  • Founded
  • TIL 2018
  • SUNS 2023
  • Country
  • TIL United States
  • SUNS United States
  • Employees
  • TIL N/A
  • SUNS N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • SUNS Real Estate Investment Trusts
  • Sector
  • TIL Health Care
  • SUNS Real Estate
  • Exchange
  • TIL Nasdaq
  • SUNS Nasdaq
  • Market Cap
  • TIL 171.7M
  • SUNS 148.2M
  • IPO Year
  • TIL 2021
  • SUNS N/A
  • Fundamental
  • Price
  • TIL $17.21
  • SUNS $11.07
  • Analyst Decision
  • TIL Buy
  • SUNS Strong Buy
  • Analyst Count
  • TIL 5
  • SUNS 3
  • Target Price
  • TIL $114.00
  • SUNS $13.92
  • AVG Volume (30 Days)
  • TIL 85.6K
  • SUNS 177.6K
  • Earning Date
  • TIL 03-04-2025
  • SUNS 03-06-2025
  • Dividend Yield
  • TIL N/A
  • SUNS 8.67%
  • EPS Growth
  • TIL N/A
  • SUNS N/A
  • EPS
  • TIL N/A
  • SUNS 1.00
  • Revenue
  • TIL N/A
  • SUNS $10,588,270.00
  • Revenue This Year
  • TIL N/A
  • SUNS $141.80
  • Revenue Next Year
  • TIL N/A
  • SUNS $53.98
  • P/E Ratio
  • TIL N/A
  • SUNS $10.71
  • Revenue Growth
  • TIL N/A
  • SUNS 1342.10
  • 52 Week Low
  • TIL $9.62
  • SUNS $8.11
  • 52 Week High
  • TIL $92.00
  • SUNS $15.74
  • Technical
  • Relative Strength Index (RSI)
  • TIL 42.69
  • SUNS N/A
  • Support Level
  • TIL $17.87
  • SUNS N/A
  • Resistance Level
  • TIL $19.61
  • SUNS N/A
  • Average True Range (ATR)
  • TIL 1.68
  • SUNS 0.00
  • MACD
  • TIL -0.06
  • SUNS 0.00
  • Stochastic Oscillator
  • TIL 5.69
  • SUNS 0.00

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: